Form D · Other
Brevena Laboratories, LLC
St. Paul, MN · CIK 0001620535
Offering snapshot reported Apr 25, 2019 · SEC filing
- Reported sold
- $750K Offering amount: $1M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Apr 15, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2019 | Initial | $750,000 | No comparison | 2 | SEC filing |
| Nov 12, 2014 | Amendment | $2,970,000 | $2,819,999vs Sep 26, 2014 | 19 | SEC filing |
| Nov 7, 2014 | Amendment | $2,970,000 | $2,819,999vs Sep 26, 2014 | 19 | SEC filing |
| Nov 6, 2014 | Amendment | $2,970,000 | $2,819,999vs Sep 26, 2014 | 19 | SEC filing |
| Sep 26, 2014 | Initial | $150,001 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-338154
Remaining securities ($250,000) will not be offered or sold, as offering deadline has passed.
Source: Form D, filed Apr 25, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Hynes | Director |
| Barbara Klein | Executive |
| Timothy Lawin | Director, Executive |
| Philip Lawin | Director |
| Julia Mc Mann | Executive |
| Harry E. Wells, Iii | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1290 Hammond Road
St. Paul, MN, 55110
St. Paul, MN, 55110